News

News

OBI Pharma to launch Phase 1 clinical trial for a new generation of carbohydrate cancer immunotherapy in 2014.

Taipei, Taiwan – 31 January 2013 – A recent paper published by the Academia Sinica explained that a new generation therapeutic cancer vaccine – Globo …

News

OBI’s company English name official renamed OBI Pharma, Inc.

News

Breast Cancer New Drug: OBI-822/821 received Taiwan FDA Approval for entering Phase III trial

Breast Cancer New Drug:OBI-822/821 received Taiwan FDA Approval for entering Phase III trial

News

DIFICID (Fidaxomicin) Approved by Taiwan Department of Health for the Treatment of CDAD

DIFICID® (Fidaxomicin) Approved by Taiwan Department of Health for the Treatment of Clostridium Difficile Associated Diarrhea (CDAD) TAIPEI, 20 July 2012 OBI Pharma, Inc. announced …